Protagonist Therapeutics Inc Sustainability Reports
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company that discovers and develops peptide-based new chemical entities. The company's therapeutics target areas of unmet need across rare and prevalent diseases including inflammation, immunology, and hematology.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG002B63KP4
7 reports from 2016 to 2025
Company Profile
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company that discovers and develops peptide-based new chemical entities. The company's therapeutics target areas of unmet need across rare and prevalent diseases including inflammation, immunology, and hematology.
Reports
7 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
